Skip links

Alexandros Spyridonidis

We are here to answer any question you may have.

Alexandros Spyridonidis

Bio

Dr. SPYRIDONIDIS ALEXANDROS, MD, PhD Professor of Hematology

Director of Bone Marrow Transplantation Unit Director Institute of Cell Therapy

Director CBMDP, Bone Marrow Donor Center
Director MSc “Cell and Gene Therapies”
Leader RIC Committee Acute Leukemia WP EBMT,
Hellenic Representative, European Union, “Tissues and Cells” JACIE Inspector for Cell Therapy

University of Patras, Greece

Spyridonidis Alexandros was born in Greece and studied medicine (MD) in Aristotle Univesity of Thessaloniki, Greece. He was trained as hematologist in the Dept. of Hematology & Oncology of U of Freiburg, Germany where he completed his PhD thesis and awarded the Venia Legendi. He was appointed as Professor of Hematology in U of Patras, Greece where he established and is currently the Director of the Bone Marrow Transplantation (www.bmtpatra.gr), the first in Greece “Centre of Bone Marrow Donor Volunteers U Patras (CBMDP)” (www.xarisezoi.gr), the “Institute of Cellular Therapy” (www.ictpatras.gr) and the international MSc Program “Cell and Gene Therapies: from Bench to Bedside and Good Manufacturing Practices“ (www.mastercgt.com). He has spent a research sabbatical leave at the NIH, USA (Prof. J.Barrett’s) working on the clinical establishment of cell therapies. The pipeline of his clinical translational research includes the preclinical and clinical GMP manufacture of an academic Cell Therapy Product (iG-Tregs) which is now evaluated in a Phase I/II study (EudraCT-2021- 006367-26). He is/was Board Member of the Hellenic Society of Hematology (HSH), Founding and Board Member of the “Hellenic Society of Gene Therapy and Regenerative Medicine”, Board Member of the Hellenic National Transplant Organization, President of the BMT Scientific Group of the HSH and Board Member of the Scientific Council of the Prefecture of Western Greece. Outside Greece, he is/was Hellenic Representative in European Union in “Tissues and Cells” Section, Co-leader of the RIC-Committee of Acute Leukemia WP of EBMT, Board Member of the “Centre of the Study of Haematological Malignancies” in Cyprous, Inspector of the JACIE/EBMT for Cell Therapies and Mentor at the H-Net Masterclass of the European Haematology Association (EHA). He has multiple publications, including a “How I treat” in Blood, and has received numerous of national and international awards and research grants from multiple sources, mainly in the field of leukemia and cellular therapy.

This website uses cookies to improve your web experience.
Explore
Drag